or
forgot password

    • cancer clinical trials in arkansas

    • TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Little Rock Hematology Oncology Associates
    Ovarian Neoplasms
    S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Cervical Cancer
    Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lymphoma
    Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Infection, Unspecified Adult Solid Tumor, Protocol Specific
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lymphoma
    Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Sarcoma
    Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lymphoma
    Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Colorectal Cancer, Metastatic Cancer
    Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
    Highlands Oncology Group - Fayetteville

    Trial Locations
    Highlands Oncology Group - Fayetteville
    Washington Regional Medical Center
    Cervical Cancer
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Metastatic Cancer, Sarcoma
    Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lymphoproliferative Disorder
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    Highlands Oncology Group - Springdale
    Springdale, Arkansas 72764
    Lung Cancer
    Matrix Metalloproteinases and Diabetic Nephropathy
    Arkansas Children's Hospital/University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72202
    Diabetes Mellitus, Type 1, Diabetic Nephropathy
    Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
    Veterans Affairs Medical Center - Little Rock (McClellan)

    Trial Locations
    Veterans Affairs Medical Center - Little Rock (McClellan)
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Lung Cancer
    Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
    Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
    Ft. Smith, Arkansas 72903
    Pancreatic Cancer
    Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma, Peripheral Primitive Neuroectodermal Tumor
    Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lymphoma
    Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Cervical Cancer
    Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Sarcoma
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Hembree Mercy Cancer Center at St. Edward Mercy Medical Center

    Trial Locations
    Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
    Highlands Oncology Group - Springdale
    Pancreatic Cancer
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Brain and Central Nervous System Tumors
    FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences

    Trial Locations
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Veterans Affairs Medical Center - Little Rock
    Colorectal Cancer
    Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
    Local Institution
    Little Rock, Arkansas
    Breast Cancer, Metastases
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Little Rock Hematology Oncology Benton

    Trial Locations
    Little Rock Hematology Oncology Benton
    Heritage Physician Group, Oncology
    University of Arkansas for Medical Sciences
    Highlands Oncology Group
    Non Small Cell Lung Carcinoma
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Neuroblastoma
    Study of Talabostat and Cisplatin in Advanced Melanoma
    University of Arkansas Medical Sciences
    Little Rock, Arkansas 72205
    Melanoma, Skin Cancer
    Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer
    The University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Breast Cancer, Metastases
    Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Study of Combination PS-341 and Thalidomide in Multiple Myeloma
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy
    Heritage Physician Group-Oncology
    Hot Springs, Arkansas 71913
    Anemia
    Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Leukemia
    Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Waldenstrom Macroglobulinemia
    D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    North Little Rock, Arkansas 72117
    Carcinoma, Renal Cell
    Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    DTPACE Followed by Tandem Transplant With MEL 200 Versus MEL/DTPACE Hybrid and DTPACE Consolidation
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

    Little Rock, Arkansas 72205-7199
    Breast Neoplasms, Neoplasm Metastasis
    STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
    Genesis Cancer Center

    Trial Locations
    Genesis Cancer Center
    Univ Of Arkansas/Arkansas Research Center
    Melanoma